logo

For the Inventor, By the Inventor

Amherst, NY, United States of America

Charles Theodore Kane, Jr

This inventor holds 4 USPTO granted patents. Top assignees: Starks Associates Inc., The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1997-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Theodore Kane, Jr. Retrieved from https://idiyas.com/inventor/charles-theodore-kane-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Location History:

  • Amherst, NY (US) (1997 - 1998)
  • East Amherst, NY (US) (2018 - 2020)

Company Filing History:

goldMedal4 out of 9 
 
Starks Associates Inc.
 patents
silverMedal3 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
bronzeMedal1 out of 3,697 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 1997-2020

Loading Chart...
4 patents (USPTO):Explore Patents
1. 10738047 - Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof (2020-08-11),
2. 10131659 - Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof (2018-11-20),
3. 5824674 - Brefeldin A derivatives and their utility in the treatment of cancer (1998-10-20),
4. 5696154 - Brefeldin A derivatives and their utility in the treatment of cancer (1997-12-09),

Title: The Innovations of Charles Theodore Kane, Jr.

Introduction

Charles Theodore Kane, Jr. is a notable inventor based in Amherst, NY (US). He has made significant contributions to the field of science and technology, particularly in the development of novel compounds with potential therapeutic applications. With a total of 4 patents to his name, Kane's work has garnered attention for its innovative approach to addressing critical health issues.

Latest Patents

Kane's latest patents include groundbreaking research on iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases. These formulations are disclosed as having anticancer and anti-inflammatory activity, showcasing the potential of these compounds in medical applications. His work emphasizes the importance of developing new therapeutic agents that can effectively combat diseases.

Career Highlights

Throughout his career, Kane has worked with various organizations, including Starks Associates Inc. and the United States Department of Health. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in health-related technologies.

Collaborations

Kane has collaborated with esteemed colleagues such as James Halpern Doroshow and Prabhakar Risbood. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.

Conclusion

Charles Theodore Kane, Jr. exemplifies the spirit of innovation through his dedicated work in developing novel therapeutic agents. His contributions to science and technology continue to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…